Sharlene Gill, Medical Oncologist and Medical Director of Staff Wellness and Engagement at BC Cancer, shared CIO Magazine’s post on LinkedIn, adding:
“Delighted to see Caroline Chung recognized for her innovation, leadership and capacity to bring people together. I’ve known Caroline since her time with us at BC Cancer many years ago and it has been a joy to see the trajectory of her career and impact.
We reconnected more recently through her leadership of WinC-AlinC – Women in Cancer-All in Cancer and I love how she always shows up with authenticity, humility and kindness even when she has so much on her plate – Congrats Caroline!”
Quoting CIO Magazine’s post:
“Dr. Caroline Chung, recognized by Reuters as a Trailblazing Woman of 2026 in Enterprise AI, served as the inaugural Vice President and Chief Data and Analytics Officer at The University of Texas MD Anderson Cancer Center, co-directing the Institute for Data Science in Oncology and holding a tenured professorship in Radiation Oncology.
A clinician specializing in CNS malignancies, she translates clinical challenges into enterprise-wide AI strategy, bridging precision medicine and patient outcomes at scale. Her global leadership spans co-president of the Quantitative Medical Imaging Coalition, co-chair of ASCO’s AI Community of Practice, advisory roles with the NIH and NCI, and co-authoring NASEM’s Digital Twins report.
Dr. Chung is a defining voice in responsible, impactful AI implementation in medicine.
Recently, in an exclusive interview with CIO Magazine, Caroline shared insights into how clinical experience, quantitative rigor, and culture-first leadership are converging to redefine cancer care. On AI trends in oncology for 2026, she flagged multimodal AI as truly transformational while calling for more research on AI implementation, impact measurement, and the human-AI interface to understand how learning and critical thinking evolve.
As Chair of Women in Cancer – All in Cancer, she credited ‘Strengthening Through Perspectives‘ events for moving the needle by fostering open dialogue across clinicians, researchers, STEM, industry, and patient advocates, stressing that sponsorship opens doors, because women and underrepresented leaders are often over-mentored and under-sponsored.”
Discover her inspiring journey here: Building Culture First AI for Cancer Care
Other articles featuring Sharlene Gill on OncoDaily.